- Recommendation ID
- NG226/10
- Question
Topical and oral medicines:
- What is the clinical and cost effectiveness of topical local anaesthetics for people with osteoarthritis?- What is the clinical and cost effectiveness of antiepileptics and antidepressants (other than duloxetine) for people with osteoarthritis?
- What is the clinical and cost effectiveness of weak oral opioids for people with osteoarthritis?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made the recommendations for research see the rationale section on topical, oral and transdermal medicines.
Full details of the evidence and the committee's discussion are in evidence review I1, evidence review I2, evidence review I3: clinical and cost effectiveness of oral, topical and transdermal medicines for the management of osteoarthritis.
Source guidance details
- Comes from guidance
- Osteoarthritis in over 16s: diagnosis and management
- Number
- NG226
- Date issued
- October 2022
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/10/2022 |